The truth is there are too many variables with a diverse business such as this for me to predict the performance metrics 12 months from now. If you believe you can, that is fine and your opinion is noted. I can only go by the previous results from the company, which were, with the exception of the write down of the PPE segment, overwhelmingly positive.
I know that earnings have been inconsistent in the past few years and may continue to be lumpy moving forward. My hope is that the new management may be able to mitigate those inconsistencies and progress the turnaround story into a sustainable growth trajectory.
Ann: 1HFY21 Appendix 4D and Half Year Report, page-23
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GAP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.010(8.70%) |
Mkt cap ! $35.50M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.5¢ | 11.0¢ | $7.336K | 64.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8695 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 9000 | 1 |
View Market Depth
| Last trade - 15.21pm 30/08/2024 (20 minute delay) ? |
| GAP (ASX) Chart |